United States Anti-Doping Agency spokesperson confirmed on Tuesday that the B Sample of UFC’s light heavyweight champion Jon Jones came back positive. Drug test occurred on July 28 in Anaheim, California prior to UFC 214. On the event, Jones reclaimed the title. After it was reported in August that the A sample contained anabolic steroid called Turinabol, Jones hoped that the B sample will clear him out. However, B sample rarely provides different results than the A sample.
“Mr. Jones ‘B’ sample has confirmed the ‘A’ sample findings. Importantly — as previously stated — due process should occur before drawing any conclusions about this matter.” – the USADA’s spokesperson said.
Jones denied taking the substance and his team is currently investigating how the substance entered his system. Jones received support from some of his teammates, including Frank Lester who wrote on his social media account the following: “This is a set up, straight up, no athlete would test clean his entire fight camp, and then randomly take some cheap f—king oral steroid between weigh-ins and fight night knowing he would be tested once he got done fighting. This is a straight set up. They are trying to ruin this kids life.”
Because Jones’ B sample came positive, the California State Athletic Commission (CSAC) took his win over Daniel Cormier at UFC 214 and turned it to no-contest. UFC still didn’t make a decision to strip the title of light heavyweight champion from Jones, but that should be expected soon. Since this is a second time Jones has been tested positive for banned substances, he could face a maximum of 4 years suspension. Last year, he was positive for Letrozole and Clomiphene, which caused him to pull out from UFC 200, and get 1-year suspension while being stripped of his title. Jones claimed that these substances came from a sexual enhancement pill.
